Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

675.40INR
23 Feb 2017
Change (% chg)

Rs5.00 (+0.75%)
Prev Close
Rs670.40
Open
Rs671.00
Day's High
Rs681.00
Day's Low
Rs667.90
Volume
264,710
Avg. Vol
459,017
52-wk High
Rs898.00
52-wk Low
Rs572.40

Latest Key Developments (Source: Significant Developments)

Sun Pharmaceutical Industries says European Medicines Agency approves Tobramycin
Thursday, 16 Feb 2017 04:29am EST 

Sun Pharmaceutical Industries Ltd : Sun Pharmaceutical Industries clarifies on news item "UK regulator approves Sun Pharma generic drug of Tobramycin" .Approval for product, is not from UK regulator but from European Medicines Agency.  Full Article

Sun Pharma to buy Novartis' cancer drug Odomzo
Wednesday, 21 Dec 2016 10:01pm EST 

Sun Pharmaceutical Industries Ltd : Says Sun Pharma to acquire branded oncology product Odomzo for global markets . Says acquisition of Odomzo from Novartis . Says greement has been signed for an upfront payment of US$ 175 million and additional milestone payments. .says Odomzo is used for treatment of adult patients with labcc that has recurred following surgery or radiation therapy.  Full Article

Sun Pharmaceutical Industries announces voluntary withdrawal of 28 ANDAs
Monday, 19 Dec 2016 09:48pm EST 

Sun Pharmaceutical Industries Ltd : Says older drug products belong to erstwhile ranbaxy laboratories ltd. And are not being marketed in us since 2008 .Says voluntary withdrawal of 28 ANDAs.  Full Article

Sun Pharmaceutical Industries says USFDA cites nine inspectional observations at Halol facility
Thursday, 8 Dec 2016 04:15am EST 

Sun Pharmaceutical Industries Ltd : USFDA inspected the company's Halol facility in Gujarat, India from November 17, 2016 through December 1, 2016 . At the conclusion of the inspection, the USFDA issued a Form-483, citing nine inspectional observations . Says intends to implement promptly any corrective actions that may be necessary as a result of the observations .None of the observations were characterized by the USFDA as repeat observations.  Full Article

Sun Pharma enters into deal to buy 85.1 pct of Russia's JSC Biosintez
Tuesday, 22 Nov 2016 09:51pm EST 

Sun Pharmaceutical Industries Ltd : Says company has entered into an agreement to acquire 85.1% of JSC Biosintez, a Russian pharmaceutical company . Days deal expected to be completed by end of 2016 . Equity consideration for shares acquired is RUB 1,526 million or approx. USD 24 million .Sun Pharma would also assume a debt of approximately USD$ 36 million as part of this transaction.  Full Article

Sun Pharmaceutical Industries signs tri-party agreement to launch malaria free India
Tuesday, 15 Nov 2016 03:41am EST 

Sun Pharmaceutical Industries Ltd : Sun Pharmaceutical Industries Ltd says Sun Pharma signing tri-party agreement to launch malaria free India . Sun Pharmaceutical Industries -agreement allows other government or private stakeholders to join Mandla project,similar project in partnership with FDEC-India . Sun Pharmaceutical Industries - ICMR, government of MP, FDEC-India sign tri-party agreement to launch malaria free India demonstration project in Mandla district .Sun Pharmaceutical Industries - project to be launched across 1,233 villages in Mandla by january 2017.  Full Article

Beijing Science Sun Pharmaceutical unit to pay penalty of 0.3 mln yuan
Friday, 19 Aug 2016 04:05am EDT 

Beijing Science Sun Pharmaceutical Co Ltd <300485.SZ>: Says its unit received report of administrative punishment from environmental protection department .Says the unit was ordered to pay penalty of about 0.3 million yuan regarding its wastewater discharge.  Full Article

Sun Pharmaceutical Industries June-qtr consol profit rises almost fourfold
Friday, 12 Aug 2016 04:46am EDT 

Sun Pharmaceutical Industries Ltd : June-quarter consol net profit 20.34 billion rupees . June-quarter consol total income from operations 82.43 billion rupees . June-quarter net profit consensus forecast was 19.04 billion rupees . Consol net profit in June-quarter last year was 5.56 billion rupees as per Ind-AS; consol net sales was 67.61 billion rupees .  Full Article

Sun Pharmaceutical extends Imatinib Mesylate Savings Card program benefits for patients in USA
Monday, 8 Aug 2016 08:32am EDT 

Sun Pharmaceutical Industries Ltd : Sun Pharma extends Imatinib Mesylate Savings Card program benefits for patients in USA . Co will continue to offer up to US$ 700 reduction on each eligible patient's initial out-of-pocket cost from their commercial insurer . Benefit will cover a patient's monthly fills for a 30-day supply of Sun pharma's imatinib mesylate prescribed for ph+cml, . Will also continue hub service wherein patients can call and speak with a trained healthcare professional .  Full Article

India's Sun Pharma gets FDA nod for generic Glumetza
Monday, 1 Aug 2016 11:44pm EDT 

Sun Pharmaceutical Industries Ltd : Sun Pharma announces U.S. FDA approval for generic Glumetza . The commercial launch of the tablets in the U.S. is expected over the next few weeks .  Full Article

More From Around the Web

BRIEF-Sun Pharmaceutical Industries says European Medicines Agency approves Tobramycin

* Sun Pharmaceutical Industries clarifies on news item "UK regulator approves Sun Pharma generic drug of Tobramycin"